We report here that the introduction of ERβ in ovarian cancer cells displaying endogenous levels of ERα leads to a strong inhibition of in vivo growth and cell dissemination, mediated through the control of ERα expression and signaling. Here, ESR2 is linked to ovarian carcinoma.